Development and Evaluation of a Chitosan-based Topical Gel of Dinalbuphine sebacate for Targeted Management of Rheumatoid Arthritis. AJP [Internet]. 2025 Jul. 21 [cited 2026 Apr. 14];19(2). Available from: http://www.asiapharmaceutics.info/index.php/ajp/article/view/6471